Back to mobile site

More on ACXP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+69.8% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Acurx Pharmaceuticals (NQ:ACXP)
Delayed: 1.57 -0.08 (4.85%)
Prev. Close $1.65  
Open$1.63 
52 Wk High$ 
52 Wk Low$ 
Day High$1.65 
Day Low$1.56 
P/E N/A  
EPS$ 
Volume52,199 

Friends, Peers and Foes (?): SNYR, LASE, AERT, DVLT, NTHI (more...)

May 19, 2026 12:26 PM Acurx Pharmaceuticals (NASDAQ: ACXP) Highlights FDA's New CDI Guidance That Could Accelerate Approval Path for Ibezapolstat
May 12, 2026 03:05 PM Form 424B3 Acurx Pharmaceuticals,
May 12, 2026 03:04 PM Form 424B3 Acurx Pharmaceuticals,
May 12, 2026 08:44 AM Acurx Pharmaceuticals (ACXP) Misses Q1 EPS by 62c
May 12, 2026 07:01 AM Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
May 12, 2026 06:07 AM Form EFFECT Acurx Pharmaceuticals,
May 12, 2026 06:07 AM Form EFFECT Acurx Pharmaceuticals,
May 11, 2026 04:07 PM Form 10-Q Acurx Pharmaceuticals, For: Mar 31
May 4, 2026 04:13 PM Acurx Pharmaceuticals (ACXP) files for 1.3M share offering by selling stockholders
May 4, 2026 04:10 PM Form S-1 Acurx Pharmaceuticals,
View All Articles

Entities mentioned with ACXP

View All Entities